The latest policy and advocacy updates related to the field of clinical and translational science.
Lawmakers reconvened in January for the 2nd session of the 116th Congress. In order to set the table for impeachment proceedings, all Fiscal Year (FY) 2020 spending bills were resolved at the end of last year along with critical healthcare policy items. The resolution of the FY 2020 appropriations process was the culmination of year-long advocacy efforts for the community and resulted in sustained ongoing investment in the full spectrum of medical research. Moreover, lawmakers went above and beyond to protect the Clinical and Translational Science Award program and reauthorize the Patient Centered Outcomes Research Institute. With a budget deal in place and elections looming in November, Congress has already begun preliminary work on the FY 2021 appropriations process.
Below, please find a summary of key funding and policy items from the FY 2020 appropriations process: